Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | AMGN | VRTX | REGN | GILD |
| Company | Urovant Sciences Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.23 | 311.49 | 477.52 | 1,042.28 | 68.24 |
| High | 16.24 | 312.54 | 477.52 | 1,047.25 | 68.33 |
| Low | 16.21 | 309.75 | 468.43 | 1,031.00 | 67.12 |
| Last | 16.24 | 311.03 | 471.41 | 1,029.94 | 67.15 |
| Change | +0.01 | +0.26 | -2.37 | -14.72 | -1.25 |
| % Change | +0.06% | +0.08% | -0.50% | -1.41% | -1.83% |
| Volume | 1,739,000 | 115,127 | 160,854 | 34,462 | 504,811 |
| 20-Day Average Volume | 143,510 | 2,345,319 | 1,233,848 | 460,366 | 9,013,370 |
| Previous Close | 16.23 | 310.77 | 473.78 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 307.95 | 475.67 | 1,036.90 | 66.69 |
| 20-Day Raw Stochastic | 87.10% | 53.34% | 34.55% | 50.00% | 50.66% |
| 20-Day Relative Strength | 65.56% | 56.62% | 58.53% | 57.62% | 51.46% |
| Weighted Alpha | +6.45 | +36.94 | +40.67 | +45.56 | -12.06 |
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | 88% Buy | 40% Sell |
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 96% Buy | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -0.35% since 06/26/24 | -0.58% since 06/26/24 | -3.15% since 06/26/24 | -2.62% since 06/26/24 |
| Low | 16.20 on 03/24/21 | 307.64 on 07/02/24 | 467.41 on 07/02/24 | 1,030.23 on 07/02/24 | 67.48 on 07/03/24 |
| High | 16.25 on 03/25/21 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +1.41% since 06/03/24 | +0.23% since 06/03/24 | +4.65% since 06/03/24 | +6.41% since 06/03/24 |
| Low | 16.10 on 03/02/21 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 16.26 on 03/19/21 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +13.60% since 04/03/24 | +15.27% since 04/03/24 | +8.89% since 04/03/24 | -4.79% since 04/03/24 |
| Low | 16.03 on 12/30/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 16.26 on 03/19/21 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +3.67% since 01/03/24 | +14.74% since 01/03/24 | +12.85% since 01/03/24 | -19.15% since 01/03/24 |
| Low | 7.15 on 11/02/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 16.26 on 03/19/21 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 166,707,904 | 122,260,352 | 115,106,896 | 85,216,352 |
| Shares Outstanding, K | 32,743 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -146,750,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -46,800,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 2.35 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 02/11/21 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.69 | 31.29 | 28.48 | 17.03 |